Difference between revisions of "Apolipoprotein B-100"
(Created page with "{| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;" ! {infobox header}| '''{{PAGENAME}}''' |- | Substrate peptide...") |
m |
||
| Line 39: | Line 39: | ||
|- | |- | ||
| Reference | | Reference | ||
| − | + | | [http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&db=PubMed&list_uids=1680857&dopt=Abstract PMID:1680857] | |
[http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&db=PubMed&list_uids=26088696&dopt=Abstract PMID:26088696] | [http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&db=PubMed&list_uids=26088696&dopt=Abstract PMID:26088696] | ||
Latest revision as of 13:45, 22 March 2017
| Apolipoprotein B-100 | |
|---|---|
| Substrate peptide name | Apolipoprotein B-100 |
| Synonyms | - |
| Determination type | In situ |
| Source | Homo sapiens |
| Subcellular localization | Cytosol |
| Swissprot ID | P04114 |
| Reactive glutamines | Not determined yet |
| Reactive lysines | Not determined yet |
| Substrate sequence | - |
| Structure | MODBASE MODEL |
| Surface accessibility | - |
| Disorder prediction | IUPred |
| Reference | PMID:1680857 |
| Notes | |
